Cook Medical Incorporated
750 Daniels Way
About Cook Medical Incorporated
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.
FOLLOW COOK MEDICAL:
Tweets by Cook Medical
360 articles with Cook Medical Incorporated
Cook Medical and Ambu A/S have agreed on terms to enter into a partnership under which Cook will distribute Ambu’s single-use, disposable duodenoscope in the U.S., following FDA clearance.
Cook provides this data to encourage further collaboration with researchers to benefit patients with peripheral arterial disease.
Forbes announced that Cook Medical has ranked 48 of 500 large companies in the America’s Best Employers of 2019 listing.
First US Patient Treated with Cook Medical’s Recently Approved Zenith® Dissection Endovascular System
Following the recent FDA approval of Cook Medical’s Zenith Dissection Endovascular System, Cooper University Health Care in Camden, New Jersey, has treated the first patient in the US with the device as part of Cook’s US commercial launch.
VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD
VIVA Physicians announced the selection of NAMSA as the independent statistical analysis group to examine individual patient-level data associated with paclitaxel-coated balloons and stent trials used in the treatment of peripheral artery disease in the superficial femoral artery.
Mauna Kea Technologies Provides an Update on Its Commercial Partnership Agreement for Urological Applications
Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, announced a mutual decision to terminate the development and distribution agreements with Cook Medical.
Jury rejects request for tens of millions of dollars and punitive damages
Findings contradict meta-analysis linking paclitaxel-coated devices and increased mortality
Shore Capital-Backed IZI Medical Products Announces Acquisition of Quick-Core® Biopsy and Breast Localization Needle Assets from Cook Medical
IZI Medical Products, LLC is pleased to announce it has acquired select soft tissue biopsy and breast localization needle assets from Cook Medical (“Cook”).
The agreement was completed on December 27, 2018. Cook will begin converting a portion of the R.J. Reynolds building in Whitaker Park into a world-class medical device manufacturing facility this year.
Cook Medical announced today the availability of the Flourish™ Pediatric Esophageal Atresia device in the U.S.
Study finds 91 percent freedom from TLR at one year and 76 percent at five years, including complex lesions
Yesterday, Cook Medical began a collaboration with Taewoong Medical to expand patient treatment options by distributing a selection of Taewoong’s stents in the U.S.
Cook Medical Incorporated was recognized as one of the best places to work in Bloomington.
The resolution was a direct result of countless hours of hard work by hundreds of people at Cook over a four-year period to improve the company’s quality system.
Cook Medical has introduced the 140 mm-length Zilver® PTX® Drug-Eluting Peripheral Stent in both 6 and 7 mm diameters in the U.S.
Cook Medical announced a letter of intent was signed with the Whitaker Park Development Authority Inc. to acquire a long-standing facility at Winston-Salem’s Whitaker Park.
Cook Medical has partnered with Taewoong Medical to distribute a selection of stents into the U.S.
Cook Medical must pay $1.2 million to compensate a man who was implanted with a Cook Celect IVC filter, said a Texas jury Thursday.
Cook Medical has announced Ross Harvey as the new director of global Customer Support & Delivery (CSD).